维普期刊资源整合服务平台（V6.5）

141篇 您的检索式：作者名="Colhoun HM"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group显示文摘	Colhoun HM SDRN Epidemiology Group	2009	Diabetologia2009，52，9：	1
2	Design of the collaborative atorvaslatin diabetes study (CARDS) in patients with type 2 diabetes显示文摘	Thomnson MJ Mackness MI	2002	Diabetes Med2002，19，：	1
3	Use of insu- lin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemi- ology Group 显示文摘	Colhoun HM SDRN Epidemiology Group	2009	Diabetologia2009，52，9：	1
4	Efficacy and safety of alirocumab as add- on therapy in high-cardiovascular- risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 rag): design and rationale of the ODYSSEY OPTIONS Studies显示文摘	ROBINSON JG COLHOUN HM BAYS HE	2014	Clin Cardiol2014，37，10：	1
5	Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group显示文摘	Colhoun HM SDRN Epidemiology Group	2009	Diabetologia2009，52，9：	1
6	Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS) : multicenter randomised placebo-controlled trial显示文摘	Colhoun HM Betteridge DJ Durrington PN	2004	Lancet2004，364，：	1
7	Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study ( CARDS ) 显示文摘	Colhoun HM Betteridge DJ Durrington PN	2009	Am J Kidney Dis2009，54，5：	1
8	Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study( CARDS): multicentre randomised place- bo-eontmlled trial显示文摘	Colhoun HM Betteridge DJ Dmrington PN	2004	Lancet2004，364，9435：	1
9	Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcifi- cation in men and women with and without type 1 diabetes显示文摘	Colhoun HM Otvos JD Rubens MB	2002	Dia- betes2002，51，：	1
10	Primary prevention of cardiovascular disease with atorvastatin in type2diabetes in the Collaborative Atorvastatin Diabetes Study(CARDS):multicentre randomised placebo-controlled trial显示文摘	Colhoun HM Betteridge DJ Durrington PN	2004	Lancet2004，364，9435：	1
11	Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study(CARDS):multicentre randomised placebo-controlled trial显示文摘	Colhoun HM Betteridge DJ Durrington PN	2004	Lancet2004，364，：	1
12	Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicenlre randomized placebo controlled trial 显示文摘	Colhoun HM Bettemdge D J Durrington PN	2004	Lancet2004，364，9435：	1
13	Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDStrial显示文摘	Colhoun HM Betteridge DJ Durrington P	2011	Diabetes2011，60，23：	1
14	Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS):Multicentre randomised placebo-controlled trial显示文摘	Colhoun HM Betteridge DJ Durrington PN	2004	Lancet2004，364，：	1
15	Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study(CARDS) : multicentre randomised placebocontrolled trial显示文摘	Colhoun HM Betteridge D J Durrington PN	2004	Lancet2004，364，21：	1
16	Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS):multicentre randomised placebo-controlled trial显示文摘	Colhoun HM Betteridge DJ Durrington PN		0，，21：	1
17	The effect of atorvastatin 6n serum lipids,lipo2 proteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischemic heart disease显示文摘	Soedamab-Muthu SS Colhoun HM Thomason MJ	2003	Atherosclerosis2003，167，：	1
18	显示文摘	Chan NN Vallance P Colhoun HM	2000	Diabetologia2000，43，：	1
19	Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvas- tatin (20 or 40 nag) or rosuvastatin (10 or 20 mg): design and ratio- nale of the ODYSSEY OPTIONS Studies 显示文摘	Robinson JG Colhoun HM Bays HE	2014	Clin Cardiol2014，37，10：	1
20	Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS) : multicentre randomised placebo-controlled trial显示文摘	Colhoun HM Betterridge DJ Durrington PN	2004	Lancet2004，364，9435：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示